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Abstract Cross-linking studies have implicated Sec61c~ as the 
principal component adjacent to newly synthesised membrane 
proteins during insertion into the endoplasmic reticulum. Using 
proteoliposomes which have been reconstituted from purified 
components of the endoplasmic reticulum [G/Jrlich, D and Rap- 
oport, T.A., Cell 75 (1993) 615-630] we have found that the Sec61 
complex, consisting of three subunits, is essential for the insertion 
of single-spanning membrane proteins. This is true for signal- 
anchor proteins of both orientations, and for proteins with a 
cleavable signal sequence. These results support the view that 
Sec61a is a major component of the ER translocation site and 
promotes both the insertion of membrane proteins and the 
translocation of secretory proteins. 
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1. Introduction 
The signal sequences which direct membrane proteins to the 
endoplasmic reticulum (ER) are well defined and of two types: 
cleavable signal sequences which are proteolytically removed 
from the nascent protein during insertion, and signal-anchor 
sequences which act to target he protein to the membrane and 
subsequently function as the transmembrane anchor of the 
protein [1]. Proteins which span the membrane once and have 
a cleavable signal sequence usually have the NH2-terminus ex- 
tracytoplasmic (denoted a type I orientation). In contrast, sig- 
nal-anchor proteins which span the membrane once can have 
either a type I or a type II (NH2-terminus cytoplasmic) orienta- 
tion. The principal factor affecting the orientation which a 
signal-anchor p otein assumes in the membrane appears to be 
the distribution of charged residues which flank the hydropho- 
bic core of the signal-anchor sequence [2-4]. 
In order to understand the mechanism by which signal-an- 
chor proteins are inserted into the membrane of the ER in the 
correct orientation we have analysed the ER components which 
interact with signal-anchor proteins during their membrane 
insertion. Signal-anchor proteins show a signal-recognition 
particle dependent targeting to the ER membrane [5] via a 
process which utilises GTP hydrolysis to drive the vectorial 
targeting of newly synthesised proteins to the ER membrane via 
an interaction with the docking protein (SRP receptor)[6]. After 
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targeting and the release of signal-anchor sequences from the 
54 kDa subunit of SRP the nascent membrane proteins are able 
to interact with putative components of the membrane inser- 
tion machinery [5]. We have used a photocross-linking ap- 
proach to identify these components and found that the major 
photocross-linking partner of nascent type I and type II signal- 
anchor proteins is an integral membrane protein denoted 
Sec61~ [7]. Other groups have identified non-glycosylated pro- 
teins of between 34 and 39 kDa as being adjacent to nascent 
membrane proteins during insertion into the ER [8,9]. Al- 
though formal identification of these proteins remains to be 
made it seems likely that these proteins are Sec61~. 
Sec61p was first identified in Saccharomyces cerevisiae [10] 
and found to be a major cross-linking partner of secretory 
proteins artificially trapped during the translocation process 
(denoted 'translocation i termediates') [11,12]. Sec61~, the 
mammalian homologue of Sec61p, was isolated via its tight 
association with ribosomes and shown to interact with nascent 
secretory proteins during translocation across the ER mem- 
brane [13]. A second protein, TRAM, was also shown to inter- 
act with nascent secretory proteins [14], in particular the NH z- 
terminal region of the cleavable signal sequence [15,16]. The 
translocation of a region of a polypeptide is a prerequisite for 
its insertion into the ER membrane and a role for Sec61p in 
membrane protein insertion was suggested by the observation 
that mutations in the gene can cause defects in the insertion of 
some membrane proteins [17,18]. Immunoprecipitation showed 
that the mammalian homologue, Sec61~, is the major cross- 
linking partner of signal-anchor p oteins when the interactions 
of the nascent chains were analysed both by photocross-linking 
and by the use of homobifunctional cross-linking reagents [7]. 
Mammalian Sec61~ is part of a protein complex which has at 
least two other subunits, Sec61fl and Sec61y [19]. Since the 
available data suggest Sec61~ plays a key role in mediating the 
insertion of signal-anchor proteins into the membrane of the 
ER we have tested this proposal using reconstituted prote- 
oliposomes prepared from purified components [20]. 
2. Materials and methods 
2.1. Materials 
Restriction enzymes were from Boehringer Mannheim, T7 RNA 
polymerase from Promega nd RNAsin from Pharmacia. [35S]Methion- 
ine was from Amersham and cycloheximide and 7-methyl-guanosine 
5'-monophosphate were supplied by Sigma. Wheat germ lysate, SRP 
and washed rough microsomes were prepared by published methods 
[21 23]. 
2.2. Preparation of proteoliposomes 
Proteoliposomes were reconstituted from purified protein compo- 
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nents and commercially available phospholipids as previously de- 
scribed [20]. The composition of the proteoliposomes was checked by 
Western blotting [20]. A total of three different sets of proteoliposome 
preparations were used for the experiments described (denoted batch 
A, batch B and batch C in Table 1). 
2.3. Transcription and translation 
The model membrane proteins used in this study were glycophorin 
C (Gly C), the invariant chain of the MHC class II complex (Ii), the 
influenza (Japan strain) haemagglutinin glycoprotein (HA) and glyco- 
phorin A (Gly A). Plasmids encoding the model proteins were tran- 
scribed using T7 RNA polymerase as described by the manufacturer 
(Promega) and the resulting RNA was translated in a wheat germ 
translation system in the presence of [35S]methionine and supplemented 
with purified signal recognition particle (SRP) and canine pancreatic 
microsomes or proteoliposomes [21]. The membrane insertion of Gly 
C and HA was performed by translating the encoding RNAs in a 25 
/A reaction volume for 30 min (Gly C) or 45 min (HA) at 26°C in the 
presence of 25 nM SRP and 1.5/11 of microsomes, proteoliposomes or 
buffer. For Gly A, a 50 #1 reaction volume containing 2/A of micro- 
somes, proteoliposomes or buffer was translated for 1 h as described 
above. In all three cases, cycloheximide was added to 2 mM and sam- 
ples analysed as described below. In the case of Ii, an SRP arrested 
fragment was generated by incubating the encoding RNA in a wheat 
germ translation system supplemented with 25 nM SRP but lacking any 
membranes. After 10 rain 7-methyl-guanosine 5'-monophosphate was 
added to a final concentration of4 mM and the incubation continued 
for a further 5 min. 1.5 fll of microsomes, proteoliposomes or buffer 
were then added, the samples incubated for 10 min and cycloheximide 
added to 2 mM. The use of N-etbylmaleirnide (NEM) to inactivate 
rough microsomes and acceptor tripeptide to inhibit asparagine linked 
glycosylation followed published protocols [24,25]. 
2.4. Membrane insertion assay 
After protein synthesis, 10% of the final translation volume was 
removed to assess total protein synthesis. The remainder of the samples 
was layered over a 150 ~1 cushion (50 mM HEPES-KOH, pH. 7.9, 
5 mM Mg(OAc)2, 500 mM KOAc and 250 mM sucrose) in Beckman 
TLAI00 tubes. These were spun for 10 min at 100,000 × g and 4°C. 
Western blot analysis for constituent proteins confirmed that both the 
Type I signal- Type II signal- 
anchor protein anchor protein 
microsomes and the various proteoliposome preparations were all pel- 
leted under these conditions (data not shown). The supernatant and 
cushion was removed and discarded and the pellets were resuspended 
in 50/11 of buffer (50 mM HEPES-KOH, pH. 7.9, 5 mM Mg(OAc)2, 
100 mM KOAc and 250 mM sucrose). For Gly C, Ii and HA, 20% of 
the resuspended pellet was TCA precipitated to assess the amount of 
membrane associated material while 70% was incubated with 0.44 mg/ 
ml proteinase K for 30 min on ice to determine the amount of protease 
protected material. For Gly A, 45% of the resuspended pellet was TCA 
precipitated and 45% incubated with 0.5 mg/ml chymotrypsin at 26°C 
for 1 h. After digestion PMSF was added to 1.5 mg/ml and samples 
TCA precipitated. The TCA precipitated material from each step of the 
assay was solubilised in gel loading buffer and samples were analysed 
on 12% SDS-polyacrylamide g ls. In the case of the proteolysed Gly 
A samples, hot sample buffer was added directly to the incubation after 
digestion. Dried gels were exposed irectly to Kodak X-Omat film for 
visualisation. For quantitative analysis the gels were analysed using a 
BAS2000 phosphorimager. 
3. Results 
3.1. Type I signal-anchor protein insertion 
The insertion of the type I signal-anchor protein, glycophorin 
C (Fig. 1), into reconstituted proteoliposomes was tested. Total 
protein synthesis was unaffected by the presence of different 
proteoliposomes, microsomes or buffer in the translation reac- 
tion (Fig. 2, panel a). Only in the presence of active microsomes 
was any glycosylated material observed (Fig. 2, panel a, lane 
7). The inclusion of a tripeptide comprising the consensus ite 
for asparagine linked oligosaccharide addition prevented this 
glycosylation (Fig. 2, panel a, lane 8). When the membrane 
fraction was isolated, the amount of Gly C associated with this 
fraction was clearly dependent upon the composition of the 
proteoliposomes. In the absence of  the Sec61 complex (Fig. 2, 
panel b, lanes 3 and 4) background levels of protein were 
observed (c.f. no membranes, Fig. 2, panel b, lane 5). Since the 
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Fig. 1. The orientation of model membrane proteins in the ER membrane. The orientation of the model membrane proteins used in this study is 
shown. The number of amino acids exposed on the cytosolic and luminal sides of the ER membrane is indicated as well as the predicted length of 
the transmembrane domain (shown in black). The proteins, HA and Gly A have cleavable signal sequences (black zig-zag) while Gly C and Ii have 
signal-anchor sequences. The number of the methionine residues which carry the radioactive label are shown for each region, and the number and 
approximate position of sites modified by asparagine linked carbohydrate side chains are indicated by the branched structure. 
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Fig. 2. The insertion of glycophorin C into proteoliposomes. The inser- 
tion of glycophorin C (Gly C) into proteoliposomes containing the 
indicated combinations of the Sec61 complex (Sec61), the docking pro- 
tein complex (DP), and the TRAM protein (TRAM) was assayed. 
Controls were nuclease treated, washed, rough microsomes (RMKN), 
RMKN which had been inactivated by NEM treatment 
(RMKN + NEM), RMKN plus a tripeptide inhibitor of asparagine 
linked glycosylation (RMKN + Pep) and the RMKN storage buffer 
alone (Buffer). Gly C shows the position of the unglycosylated protein 
and Gly C + CHO shows the position of the glycosylated protein (1 gly- 
cosylation site). Panel a shows total protein synthesis, panel b shows 
the membrane associated material, i.e. the material found in the pellet 
after centrifugation as described in materials and methods, and panel 
c shows the protease protected material. The filled arrow heads show 
the position of Gly C (lanes 1, 2, 3 and 8) and Gly C + CHO (lane 7) 
which was resistant to proteolytic digestion. 
reconstituted proteoliposomes lack the enzymes necessary to 
glycosylate asparagine residues [20] this modification is not 
observed and the mobility of the protein is identical to the 
non-glycosylated protein produced in the presence of canine 
pancreatic microsomes (Fig. 2, panel b, lane 8). In the control 
microsomes most of the membrane associated protein is glyco- 
sylated (Fig. 2, panel b, lane 7). Canine pancreatic microsomes 
which had been treated with NEM [24] to prevent membrane 
insertion had a significant fraction of Gly C associated with the 
membrane pellet. The samples were treated with proteinase K
to determine what fraction of the membrane associated mate- 
rial was actually inserted into the membrane. Only prote- 
oliposomes containing the Sec61 complex showed significant 
protease protected material (Fig. 2, panel c, lanes 1 and 2), the 
size of this product was identical to that obtained in micro- 
somes where asparagine linked glycosylation had been inhib- 
ited (Fig. 2, panel c, lane 8). The presence of the TRAM protein 
in addition to the docking protein complex and the Sec61 com- 
plex did not affect the efficiency of Gly C insertion (Table 1). 
The orientation of Gly C in microsomes was confirmed by the 
observation that all the protease protected material was glyco- 
sylated at the single site present in the NH2-terminus (Fig. 2, 
panel c, lane 7). Since no glycosylation occurs with prote- 
oliposomes, the predicted sizes of the protease protected NH2 
and COOH domains of Gly C are not dramatically different 
(see Fig. 1.) However, six of the total of eight methionine 
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Table 1 
The efficiency of membrane protein insertion into proteoliposomes 
Protein Gly C Ii HA Gly A 
Proteolip. Batch A B B C 
Sec61, DE TRAM 275 36 54 134 
Sec61, DP 273 32 3 133 
DP, TRAM 0 0 0 0 
Sec61, TRAM n.d. n.d. n.d. 20 
DP 0 0 0 n.d. 
Buffer 0 0 0 0 
RMKN + NEM 17 2 0 14 
RMKN I00 100 100 100 
The material protected against proteolytic digestion (Figs. 2 to 5, panel 
c) was quantified using a Fuji BAS2000 phosphorimager and the ac- 
companying Fuji software package. In each case the value obtained 
with the rough microsome control (RMKN) was defined as 100% and 
all the other figures given are relative to this. Comparisons are therefore 
only valid within the individual columns. The glycosylated product was 
quantified for the RMKN + NEM and the RMKN samples (i.e. Gly 
C + CHO of Fig. 2, panel c, lanes 6 and 7; Ii + 2 CHO of Fig. 3, panel 
c, lanes 6 and 7; HA + 7 CHO of Fig. 4, panel c, lanes 6 and 7; and Gly 
A + CHO of Fig. 5, panel c, lanes 6 and 7). For all other samples the 
non-glycosylated product was quantified (i.e. Gly C of Fig. 2, panel c, 
lanes 1 to 5; Ii of Fig. 3, panel c, lanes 1 to 5; HA of Fig. 4, panel c, 
lanes 1 to 5; and Gly A of Fig. 5, panel c, lanes 1 to 5). 
residues are present in the NH2-terminal domain, one is in the 
transmembrane domain and one in the COOH-terminal do- 
main. Of the total radiolabelled protein which was membrane 
associated (Fig. 2, panel b), an estimated 25% was protected 
against proteolysis both by the rough microsomes (Fig. 2, panel 
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Fig. 3. The insertion of the invariant chain into proteoliposomes. The 
insertion of the invariant chain (Ii) into proteoliposomes containing the 
indicated combinations of the Sec61 complex (Sec61), the docking pro- 
tein complex (DP), and the TRAM protein (TRAM) was assayed. 
Controls were nuclease treated, washed, rough microsomes (RMKN), 
RMKN which had been inactivated by NEM treatment 
(RMKN + NEM) and the RMKN storage buffer alone (Buffer). li 
shows the position of the unglycosylated protein and Ii + 2CHO shows 
the position of the fully glycosylated protein (2 glycosylation sites). 
Panel a shows total protein synthesis, panel b shows the membrane 
associated material, and panel c shows the protease protected material. 
The filled arrow heads show the position of Ii which was resistant to 
proteolytic digestion (lanes 1 and 2). 
J. Oliver et al./FEBS Letters 362 (1995) 126-130 129 
1 2 3 4 5 6 7  
a) HA + 7 CHO 
Pr( 
HA 
I m 
RMKN + NEM 
RMKN 
Buffer 
[ Proteoliposomes J ROugh Microsornes 
Fig. 4. The insertion of the haemagglutinin glycoprotein into prote- 
oliposomes. The insertion of the haemagglutinin glycoprotein (HA) 
into proteoliposomes containing the indicated combinations of the 
Sec61 complex (Sec61), the docking protein complex (DP), and the 
TRAM protein (TRAM) was assayed. Controls were nuclease treated, 
washed, rough microsomes (RMKN), RMKN which had been inac- 
tivated by NEM treatment (RMKN + NEM) and the RMKN storage 
buffer alone (Buffer). HA shows the position of the unglycosylated 
protein and HA + 7CHO shows the position of the fully glycosylated 
protein (7 glycosylation sites). Panel a shows total protein synthesis, 
panel b shows the membrane associated material, and panel c shows 
the protease protected material. 
c, lane 7) and by the functional proteoliposomes (Fig. 2, panel 
c, lanes 1 and 2) (data not shown). The similar levels of protec- 
tion confirm that the bulk of the Gly C has inserted into the 
proteoliposomes in the correct orientation as observed in vivo 
[26,27]. A small amount of undigested material was observed 
with both the proteoliposomes and microsomes (Fig. 2, panel 
c, arrowheads). 
3.2. Type H signal-anchor protein insertion 
As a model type II signal anchor protein the invariant chain 
of the MHC class II complex was used [28]. The total protein 
synthesis was not dramatically affected by the different prote- 
oliposome additions (Fig. 3, panel a). Ii was only found in the 
membrane fraction when functional microsomes (Fig. 3, panel 
b, lane 7) or proteoliposomes containing the Sec61 complex 
were used (Fig. 3, panel b, lanes 1 and 2). In all cases this 
material was protected against proteolysis with the loss of only 
3 kDa representing the N-terminal exposed tail (Fig. 1). Both 
proteoliposome preparations contained a small amount of un- 
digested Ii (Fig. 3, panel c, arrowheads). As for Gly C, the 
presence of TRAM in the reconstituted proteoliposomes had 
no significant effect on the efficiency of Ii insertion (Table 1). 
3.3. Insertion of type/proteins with a cleavable signal sequence 
Influenza haemaglutinin (HA) is a large type I membrane 
protein with a cleavable signal sequence [29]. Analysis showed 
that the presence of the Sec61 complex in the reconstituted 
proteoliposomes was essential for both membrane association 
(Fig. 4, panel b, lane 1) and membrane insertion (Fig. 4, panel 
c, lane 1). In contrast o the two signal-anchor proteins, the 
TRAM protein was also essential for membrane association 
and insertion (Table 1). In the absence of the TRAM protein, 
almost no HA was recovered in the membrane pellet (Fig. 4, 
panel b, lane 2) or was protected against protease (Fig. 4, panel 
c, lane 2). 
A second type I membrane protein with a cleavable signal 
sequence, glycophorin A [30], was analysed to determine if a 
requirement for TRAM was specific for this class of proteins. 
Gly A was found to be associated with all proteoliposomes 
which contained the Sec61 complex, whether or not the TRAM 
protein was also present (Fig. 5, panel b, lanes 1, 2 and 4). 
Protease resistant material, indicating insertion, was observed 
in the proteoliposomes containing the Sec61 complex and DP, 
or Sec61 complex, DP and TRAM (Fig. 5, pane c, lanes 1 and 
2). The amount of protease protected material was not influ- 
enced by the presence of the TRAM protein (Table 1). Al- 
though a large amount of material was found associated with 
proteoliposomes containing the Sec61 complex and TRAM but 
lacking DP (Fig. 5, panel b, lane 4), only a small fraction of this 
material was protected against proteolysis (Fig. 5, panel c, lane 
4). 
4. Discussion 
The results presented above show that the Sec61 complex is 
required for the correct insertion of all types of single spanning 
membrane proteins. A role for Sec610~ in this process had been 
proposed on the basis that it is the major cross-linking partner 
of type I and type II signal-anchor proteins [7]. These results 
are in agreement with those of G6rlich and Rapoport [20] who 
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Fig. 5. The insertion of glycophorin A into proteoliposomes. The inser- 
tion of glycophorin A (Gly A) into proteoliposomes containing the 
indicated combinations of the Sec61 complex (Sec61), the docking pro- 
tein complex (DP), and the TRAM protein (TRAM) was assayed. 
Controls were nuclease treated, washed, rough microsomes (RMKN), 
RMKN which had been inactivated by NEM treatment 
(RMKN + NEM) and the RMKN storage buffer alone (Buffer). Gly 
A shows the position of the unglycosylated protein and Gly A + CHO 
shows the position of the glycosylated protein (1 glycosylation site). 
Panel a shows total protein synthesis, panel b shows the membrane 
associated material, and panel c shows the protease protected material. 
The filled arrow heads how the position of Gly A which was resistant 
to proteolytic digestion (lanes 1 and 2). 
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showed that the Sec61 complex was required for the insertion 
of a type I membrane protein with a cleavable signal sequence 
(vesicular stomatitis virus glycoprotein) and a type II signal 
anchor protein (asialoglycoprotein receptor). Our results how 
that the Sec61 complex is necessary and sufficient for the cor- 
rect insertion of type I signal-anchor proteins suggesting that 
no additional proteins are required to promote the transloca- 
tion of the NHz-terminus of these proteins [4,7]. This observa- 
tion is in contrast o the situation in E. coli where the translo- 
cation of a comparable NH2-terminal domain has been shown 
to occur independently of the sec machinery normally responsi- 
ble for protein translocation [31]. 
Our results also show that a requirement for the TRAM 
protein is not restricted to any particular class of membrane 
proteins. In this paper we show examples of type I signal- 
anchor proteins, type II signal anchor proteins and type I mem- 
brane proteins with a cleavable signal sequence which are all 
efficiently inserted into proteoliposomes in the absence of 
TRAM. In other cases the insertion of type I membrane pro- 
teins with a cleavable signal sequence shows an absolute de- 
pendency on TRAM [20 and this study] while the insertion of 
a type II signal-anchor p otein is stimulated over two fold [20]. 
These results mirror the effect of TRAM on the efficiency of 
secretory protein translocation into proteoliposomes which 
varies widely depending on the secretory protein studied [20]. 
Our observation that type I and type II signal-anchor proteins 
can be correctly inserted into the membrane in the absence of 
TRAM suggests that this protein does not play a universal role 
in orienting signal-anchor sequences during membrane inser- 
tion [32]. A direct role for the Sec61 complex in mediating the 
insertion of all classes of single-spanning membrane proteins at 
the ER has now been established. The mechanism by which this 
occurs remains to be elucidated. 
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